癌症相关血栓发病率随时间上升且与死亡率增加相关
调整竞争死亡风险后,胰腺癌、脑癌、卵巢癌和肺癌的12个月累积发病率最高,乳腺癌和前列腺癌最低。2014至2017年诊断的患者较2005至2007年诊断者血栓风险更高,且癌症相关血栓与所有恶性肿瘤的全因死亡率增加相关(HR范围1.89至4.79)。
要点
- 胰腺癌、脑癌、卵巢癌和肺癌的癌症相关血栓12个月累积发病率最高。
- 2014至2017年诊断癌症的患者较2005至2007年诊断者血栓风险更高。
- 癌症相关血栓与所有恶性肿瘤的全因死亡率增加相关(HR 1.89至4.79)。
核心结论
- 癌症相关血栓的发病率随时间增加,主要由肺栓塞±深静脉血栓的增加驱动。
- 癌症相关血栓的发病率因肿瘤类型、分期及性别、种族/民族和合并症等个体因素而异。
- 对于所有肿瘤类型,癌症相关血栓均与死亡率增加相关。
研究设计与样本
- 将加州癌症登记与全州住院数据库链接,识别2005至2017年间诊断的13种最常见恶性肿瘤患者。
- 调整竞争死亡风险后计算6个月和12个月癌症相关血栓累积发病率,并采用Cox比例风险回归模型分析危险因素及对全因死亡率的影响。
主要发现
- 胰腺癌、脑癌、卵巢癌和肺癌患者的12个月癌症相关血栓累积发病率最高,乳腺癌和前列腺癌患者最低。
- 对于大多数恶性肿瘤,男性、转移性疾病、更多合并症以及非洲裔美国人(相较于非西班牙裔白人)的癌症相关血栓风险最高。
- 2014至2017年诊断癌症的患者较2005至2007年诊断者癌症相关血栓风险更高。
- 癌症相关血栓与所有恶性肿瘤的全因死亡率增加相关(HR范围1.89至4.79)。
临床怎么用
- 临床应关注癌症相关血栓发病率随时间上升的趋势,尤其针对肺栓塞±深静脉血栓的增加。
- 应根据肿瘤类型、分期以及性别、种族/民族和合并症等个体因素评估癌症相关血栓风险。
- 对于所有恶性肿瘤患者,应认识到癌症相关血栓与死亡率增加相关,需加强血栓风险管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cancer-associated thrombosis (CAT) is an important cause of morbidity and mortality for patients with malignancy and varies by primary cancer type, stage, and therapy. We aimed to characterize the incidence, risk factors, temporal trends, and the effect on mortality of CAT. The California Cancer Registry was linked to the statewide hospitalization database to identify individuals with the 13 most common malignancies diagnosed between 2005 and 2017 and determine the 6- and 12-month cumulative incidence of CAT by venous thromboembolism (VTE) location, tumor type, and stage after adjusting for competing risk of death. Cox proportional hazard regression models were used to determine risk factors associated with CAT and the effect of CAT on all-cause mortality. 942 019 patients with cancer were identified; 62 003 (6.6%) had an incident diagnosis of CAT. Patients with pancreatic, brain, ovarian, and lung cancer had the highest, and patients with breast and prostate cancer had the lowest 12-month cumulative incidence of CAT. For most malignancies, men, those with metastatic disease and more comorbidities, and African Americans (vs non-Hispanic Whites) were at highest risk for CAT. Patients diagnosed with cancer between 2014 and 2017 had a higher risk of CAT compared with those diagnosed between 2005 and 2007. CAT was associated with increased overall mortality for all malignancies (HR ranges 1.89 to 4.79). The incidence of CAT increased over time and was driven by an increase in pulmonary embolism±deep vein thrombosis (PE±DVT). CAT incidence varies based on tumor type and stage and on individual risk factors including gender, race/ethnicity, and comorbidities. For all tumor types, CAT is associated with an increased mortality.
引用
- Mahajan A, Brunson A, Adesina O, et al. The incidence of cancer-associated thrombosis is increasing over time. Blood Adv. 2022. PMID: 34649273. doi:10.1182/bloodadvances.2021005590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。